Quantum-si INC

Quantum-Si Incorporated received a notice from Nasdaq indicating its common stock has fallen below the $1.00 minimum bid price requirement for continued listing.

Quantum-Si Incorporated has entered into a 10-year lease agreement for a new 54,374 square foot office, laboratory, and manufacturing facility in San Diego, California.

Quantum-Si Incorporated successfully reelected its board of directors and ratified its independent auditor at the 2026 Annual Meeting.

Quantum-Si announced first quarter 2026 results, highlighting successful sequencing on integrated Proteus instruments and continued progress towards commercial launch.

Quantum-Si Incorporated announced its fourth quarter and full year 2025 financial results, revealing a list price for its Proteus platform and providing 2026 financial guidance.

Quantum-Si Incorporated updated the investment community on its business, highlighting the upcoming Proteus platform and its strategic roadmap.

Quantum-Si Incorporated reported its first quarter 2026 financial results, showing a significant decrease in revenue and gross profit, largely attributed to customers deferring purchases in anticipation of the upcoming Proteus platform launch.

Quantum-Si Incorporated reported a significant increase in net loss for Q3 2025, driven by one-time lease termination and legal settlement expenses, despite successful capital raises.

Quantum-Si Incorporated reported an increased net loss for the six months ended June 30, 2025, despite a year-over-year revenue increase, while securing significant capital through recent equity offerings.

Quantum-Si's Q1 2025 revenue increased by 84.2% year-over-year, driven by higher product sales, while the company continues to manage operating expenses and strategic initiatives.

Quantum-Si saw a significant increase in revenue in Q3 2024 compared to the same period last year, but continues to operate at a loss.

Quantum-Si's second quarter 2024 results show a significant increase in revenue driven by product sales, particularly the Platinum instrument, while also highlighting ongoing operational adjustments and strategic shifts.

Quantum-Si's 2024 10-K filing reveals a revenue increase alongside ongoing net losses as the company progresses with its commercial launch and product development.

Quantum-Si's 10-K filing provides a detailed overview of its capital stock, including Class A and Class B common stock, preferred stock, and warrants, along with associated rights and restrictions.

Quantum-Si Inc. reports a Form 4 filing detailing the sale of company stock by GC & Corp. Secretary Christian LaPointe to cover withholding taxes related to vested restricted stock units.

Quantum-Si Inc. CFO Jeffry R. Keyes sold shares to cover tax obligations related to restricted stock unit vesting.

Quantum-Si Chief Product Officer John S. Vieceli sold shares of Class A Common Stock to cover tax withholding obligations related to restricted stock unit vesting.

Quantum-Si CEO Jeffrey Alan Hawkins sold shares to cover tax withholding obligations related to vested restricted stock units.

Quantum-Si Inc. director Kevin Rakin has reported transactions involving Class A Common Stock and stock options, including a distribution in kind and the acquisition of vested options.

Director Scott Mendel reported a transaction involving the acquisition of Class A Common Stock and stock options for Quantum-Si Inc.

Quantum-Si Incorporated announces its 2026 annual meeting of stockholders to be held virtually on May 15, 2026, to vote on director elections, auditor ratification, and executive compensation.

Quantum-Si Incorporated has filed a definitive proxy statement with the SEC, indicating upcoming shareholder actions.

Quantum-Si Incorporated will hold its 2025 annual meeting of stockholders virtually on May 16, 2025, to elect directors, ratify the appointment of its accounting firm, and approve executive compensation.

Quantum-Si Incorporated is asking stockholders to approve amendments to its certificate of incorporation, including removing the director cap and setting a sunset date for Class B common stock conversion.

Quantum-Si Incorporated is holding its annual shareholder meeting on May 15, 2024, to vote on key proposals including the election of directors, ratification of the auditor, executive compensation, and amendments to the company's certificate of incorporation.

Quantum-Si Incorporated is holding its 2024 annual meeting of stockholders virtually on May 15, 2024, to vote on the election of directors, ratification of the company's auditor, executive compensation, and proposed amendments to the company's certificate of incorporation.

Jonathan Rothberg, founder of Quantum-Si, has established a Rule 10b5-1 trading plan to sell up to 8.97 million Class A common shares for estate planning purposes, commencing January 2026.

The Vanguard Group filed an amendment to its Schedule 13G, reporting a 4.77% beneficial ownership stake in Quantum-Si Inc. common stock.

The Vanguard Group has reported a 5.3% beneficial ownership stake in Quantum-Si Inc's common stock as of June 30, 2025, held for investment purposes.

ARK Investment Management LLC and its CEO, Catherine D. Wood, have reduced their beneficial ownership in Quantum-Si Inc. to 4.77% of the common stock, as disclosed in an Amendment No. 8 to their Schedule 13G filing.

ARK Investment Management LLC and Catherine D. Wood have filed an Amendment No. 7 to their Schedule 13G, reporting a continued beneficial ownership of 5.34% in Quantum-Si Inc.'s Common Stock as of March 31, 2025.

ARK Investment Management LLC has filed an amended Schedule 13G, reporting a 7.21% beneficial ownership stake in Quantum-Si Inc. as of December 31, 2024.

Nikko Asset Management Americas, Inc. has filed an amendment to its Schedule 13G, disclosing a 4.85% beneficial ownership stake in Quantum-Si Inc.'s Class A common stock as of December 31, 2024.